Clinical Trials Directory

Trials / Completed

CompletedNCT00803335

The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse

The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse: A Randomized Control Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
54 (actual)
Sponsor
TriHealth Inc. · Academic / Other
Sex
Female
Age
45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out how long it takes the vagina to respond to hormonal vaginal cream in women with pelvic organ prolapse (bulge in the vagina). It also will address the appropriate amount to use prior to vaginal repair of pelvic organ prolapse.

Detailed description

Subjective and objective vaginal health symptoms, validated pelvic floor questionnaires, cytology and histology will be analyzed.

Conditions

Interventions

TypeNameDescription
DRUGVaginal conjugated estrogen cream 0.5gmWomen in this arm will apply 0.5gm vaginal estrogen cream nightly until surgery.
DRUGVaginal conjugated estrogen cream 1.0gmWomen in this arm will apply 1.0gm vaginal estrogen cream nightly until surgery.

Timeline

Start date
2008-12-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2008-12-05
Last updated
2015-05-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00803335. Inclusion in this directory is not an endorsement.